Meet us at Conference RegLek EAEU 2019 in MoscowApril 15, 2019
Ukrainian government simplifies registration of medicines from the U.S., EU and certain other developed countries
On June 16, 2016, the President of Ukraine signed the Amendments to the Medicines Act, which are intended to simplify the procedure of state registration of medicines coming from countries with strong established regulatory requirements, institutions, and procedures. The changes will become effective starting from their official publication day and responsible government agencies must still adjust certain bylaws to implement them.
Extended list of medicines subject to the simplified procedure
Now all medicines (drugs) registered by a competent authority of the USA (i.e., FDA), Switzerland, Canada, Australia, Japan, and the EU are now subject to the simplified registration procedure. Whereas the previous version of the Medicines Act allowed such simplified procedures only for medicines that treat tuberculosis, HIV/AIDS, viral hepatitis, oncological, and rare (orphan) illnesses.
Read Full article HERE.
Digital Pharma: Intelligent Pharmaceutical Enterprise in Kiev on April 11April 12, 2019
Participation in DIA Europe 2019April 01, 2019
Participation in the world’s largest pharmaceutical exhibition, CPhI WorldwideNovember 30, 2018
eRA 2019 conferenceNovember 28, 2018
EMA identifies gaps in industry preparedness for BrexitJuly 27, 2018
Коллегия ЕЭК приняла Руководство по общим вопросам клинических исследованийJuly 27, 2018
Коллегия ЕЭК утвердила Руководство по валидации аналитических методикJuly 27, 2018
Russia and Bulgaria signed cooperation agreementJuly 27, 2018
EU and Japan reinforce their collaboration on inspections of medicine manufacturersJuly 20, 2018